Cancer Research The Future of Cancer Research: Science and Patient Impact  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kemp, Z. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kemp, Z. E.
[Cancer Research 66, 5003-5006, May 15, 2006]
© 2006 American Association for Cancer Research


Priority Reports

Evidence of Linkage to Chromosome 9q22.33 in Colorectal Cancer Kindreds from the United Kingdom

Zoe E. Kemp1, Luis G. Carvajal-Carmona1, Ella Barclay1, Margaret Gorman1,2, Lynn Martin1, Wendy Wood3, Andrew Rowan1, Claire Donohue1, Sarah Spain1, Emma Jaeger1, D. Gareth Evans4, Eamonn R. Maher5, Timothy Bishop6, Huw Thomas2, Richard Houlston3, Ian Tomlinson1,2 and the Colorectal Tumour Gene Identification Study Consortium

1 Molecular and Population Genetics Laboratory, Cancer Research UK, London, United Kingdom; 2 Colorectal Cancer Unit, Cancer Research UK, St Mark's Hospital, Harrow, United Kingdom; 3 Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 4 University Department of Medical Genetics and Regional Genetics Service, St Mary's Hospital, Central Manchester Healthcare Trust, Manchester, United Kingdom; 5 Section of Medical and Molecular Genetics, University of Birmingham and West Midlands Regional Genetics Service, Birmingham Women's Hospital, Birmingham, United Kingdom; and 6 Genetic Epidemiology Laboratory, Cancer Research UK, St James' University Hospital, Leeds, United Kingdom

Requests for reprints: Ian P.M. Tomlinson, Molecular and Population Genetics Laboratory, Cancer Research UK, 44 Lincoln's Inn Fields, London WC2A 3PX, United Kingdom. Phone: 44-207-2692884; Fax: 44-207-2693093; E-mail: ian.tomlinson{at}cancer.org.uk.

About 30% of all colorectal cancers are thought to have a genetic basis and the known predisposing genes can only account for a small fraction of cases. A previous report suggested that a colorectal cancer candidate gene, explaining at least 20% of colorectal cancer cases with family history, was located within a 25 cM region on chromosome 9q22.2-q31.3. We typed 16 polymorphic markers encompassing the region of putative linkage in 57 colorectal tumor families from the United Kingdom. Known Mendelian syndromes had been excluded. We found suggestive evidence of linkage, as positive parametric (HLOD = 1.23) and nonparametric (NPL = 1.21, P = 0.11) LOD scores were obtained by analysis of the whole family set. Enrichment for cases with a priori genetic etiology by analyzing families with at least one person affected at <45 years of age (n = 39 families) gave a maximum multipoint NPL score of 2.65 (P = 0.007). In this group, significant NPL scores >1.67 (P < 0.05) were found in a 6.5 cM region between D9S1851 and D9S277. With a more stringent threshold (NPL>2.4, P < 0.01), the linked region was 1.7 cM between D9S971 and D9S272/D9S173. Exclusion from the analysis of kindreds with a phenotype of multiple polyposis also found evidence of linkage in the same region (NPL = 2.47 at close to D9S277, P = 0.009). The type I transforming growth factor-ß receptor, a prime candidate gene, was excluded as a cause of disease. The results presented here further support the existence of a colorectal cancer susceptibility gene on chromosome 9q and refine its likely location. (Cancer Res 2006; 66(10): 5003-6)




This article has been cited by other articles:


Home page
ScienceHome page
L. Valle, T. Serena-Acedo, S. Liyanarachchi, H. Hampel, I. Comeras, Z. Li, Q. Zeng, H.-T. Zhang, M. J. Pennison, M. Sadim, et al.
Germline Allele-Specific Expression of TGFBR1 Confers an Increased Risk of Colorectal Cancer
Science, September 5, 2008; 321(5894): 1361 - 1365.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
D. Daley, W. Morgan, S. Lewis, J. Willis, R. C. Elston, S. D. Markowitz, and G. L. Wiesner
Is TGFBR1*6A a Susceptibility Allele for Nonsyndromic Familial Colorectal Neoplasia?
Cancer Epidemiol. Biomarkers Prev., May 1, 2007; 16(5): 892 - 894.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
Y. Xu and B. Pasche
TGF-{beta} signaling alterations and susceptibility to colorectal cancer
Hum. Mol. Genet., April 15, 2007; 16(R1): R14 - R20.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
Z. Kemp, L. Carvajal-Carmona, S. Spain, E. Barclay, M. Gorman, L. Martin, E. Jaeger, N. Brooks, D. T. Bishop, H. Thomas, et al.
Evidence for a colorectal cancer susceptibility locus on chromosome 3q21-q24 from a high-density SNP genome-wide linkage scan
Hum. Mol. Genet., October 1, 2006; 15(19): 2903 - 2910.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.